2021 annual financial data

Corbus Pharmaceuticals Holdings 2021 Operating cash flow margin

Direct answer

Operating cash flow margin was -5,464.83%.

Operating income was -55.99M USD and net income was -45.55M USD.
Operating cash flow was -48.18M USD.

Get free Corbus Pharmaceuticals Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
881,705 USD
Operating income
-55.99M USD
Net income
-45.55M USD
Operating cash flow
-48.18M USD